Thrombolysis has become established as an acute treatment for human stroke. But despite
multiple clinical trials, neuroprotective strategies have yet to be proved effective in humans.
Here we discuss intrinsic tissue mechanisms of ischaemic brain injury, and present a
perspective that broadening of therapeutic targeting beyond excitotoxicity and neuronal
calcium overload will be desirable for developing the most effective neuroprotective
therapies.